Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS APRIL ISSUE PUBLISHED
  • APRIL 2021 Issue has been successfully launched on 1 April 2021.

Abstract

A REVIEW ON CHARACTERISTICS AND ANALYTICAL METHODS OF PITAVASTATIN: A POTENT STATIN DRUG

Shivani Sharma, Navdeep Singh*, Abhinay, Amar Deep Ankalgi, Arti Rana, Mahendra Singh Ashawat

ABSTRACT

The distinctive solutions are utilized within the treatment of hyperlipidemia join the fibric corrosive subordinates such as clofibrate, fenofibrate; bile corrosive sequestrants e.g. colestipol; cholesterol retention inhibitors e.g. ezetimibe; HMG CoA reductase inhibitors e.g. lovastatin, rosuvastatin, simvastatin and pitavastatin. Pitavastatin is novel medicate utilized within the treatment of hyperlipidemia. It must be given in single or in mixture with distinctive antihyperlipidemic specialists. Pitavastatin may be a exceptionally strong specialist called HMG CoA reductase inhibitors, or "statins." Pitavastatin lower the levels of low-density lipoprotein, or LDL and triglycerides within the blood, whereas expanding levels of high-density lipoprotein, or HDL. An colossal number of techniques counting Tall Execution Fluid chromatography (HPLC), UV–Visible spectroscopy are utilized for the assurance pitavastatin. There are different explanatory strategies utilized for sedate examination and these strategies have been approved agreeing to ICH rules (Q1A R2). Hence, this procedure can be securely utilized for standard pitavastatin quality control tests.

Keywords: Hyperlipidemia, Antihyperlipidemic drugs, Pitavastatin, Analytical methods, HPLC.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More